FindTrial
Sign In

STUDY OF PREOPERATIVE AND POSTOPERATIVE IL-2 IMMUNOTHERAPY IN PANCREATIC CANCER SURGERY - RANDOMIZED PHASE 2 STUDY

STUDY OF PREOPERATIVE AND POSTOPERATIVE IL-2 IMMUNOTHERAPY IN PANCREATIC CANCER SURGERY - RANDOMIZED PHASE 2 STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
EU CTR
Registry ID
EUCTR2004-002033-39-IT
Enrollment
Unknown
Registered
2004-08-05
Start date
2004-08-02
Completion date
Unknown
Last updated
2012-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PREVENTION OF IMMUNODEFICENCY IN PANCREATIC CANCER UNDERGOING SURGERY Level: PT Classification code 10062012

Interventions

Trade Name: L03AC01- Aldesleuchina - Proleukin ev 1fl 18 MUI 5ml Product Name: NA Aldesleuchina Product Code: NA Pharmaceutical Form: Powder for solution for injection INN or Proposed INN: Aldesleuki

Sponsors

AZIENDA OSPEDALIERA SAN GERARDO DI MONZA
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Main Objective: ;Secondary Objective: ;Primary end point(s):—

Countries

Italy

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026